How should the dose of Armour Thyroid (desiccated thyroid extract) be adjusted in a patient taking 180 µg daily with an elevated thyroid‑stimulating hormone (TSH) of 10.8 mIU/L?

Dose Adjustment for Armour Thyroid with Elevated TSH

Increase the Armour Thyroid dose by 15-30 mg (to 195-210 mg daily), recheck TSH and free T4/T3 levels in 4-6 weeks, and assess for compliance and malabsorption since the current 180 mg dose suggests inadequate response. 1

Immediate Assessment

Before adjusting the dose, verify the following critical factors:

• Check medication compliance – The FDA label explicitly states that "failure to respond to doses of 180 mg suggests lack of compliance or malabsorption" 1
• Rule out biotin interference – If the patient takes biotin supplements, these must be stopped at least 2 days before thyroid testing as they can falsely elevate TSH readings 1
• Assess for drug interactions – Particularly iron, calcium supplements, proton pump inhibitors, or estrogen therapy that may impair absorption 1

Rationale for Dose Increase

Your patient's TSH of 10.8 mIU/L indicates clear undertreatment requiring intervention:

• TSH >10 mIU/L warrants treatment intensification – Guidelines establish that TSH levels above 10 mIU/L create a compelling basis for treatment adjustment to prevent progression to overt hypothyroidism and potential cardiovascular consequences 2
• Current dose is at the upper threshold – The FDA label notes that most patients require 60-120 mg/day, with 180 mg representing a dose where non-response should trigger investigation 1

Specific Dosing Algorithm

Step 1: Increase by 15-30 mg increments

• Add 15-30 mg to the current 180 mg dose (total: 195-210 mg daily) 1
• The FDA label recommends increments of 15 mg every 2-3 weeks for dose adjustments 1

Step 2: Monitor timing

• Recheck TSH, free T4, and free T3 levels in 4-6 weeks 1
• The FDA label specifies that "adequate therapy usually results in normal TSH and T4 levels after 2 to 3 weeks of therapy" 1

Step 3: Target parameters

• Aim for TSH in the normal reference range (typically 0.5-4.5 mIU/L) 1
• Maintenance dosages of 60-120 mg/day "usually result in normal serum T4 and T3 levels," though this patient clearly requires more 1

Critical Safety Considerations

Cardiovascular monitoring is essential:

• Watch for angina – The appearance of chest pain is an absolute indication for dose reduction 1
• Monitor heart rate – Desiccated thyroid can cause transient increases in heart rate and has been associated with cardiovascular events when combined with other medications 3
• If the patient has long-standing hypothyroidism or suspected cardiovascular disease, proceed cautiously with smaller 15 mg increments 1

Common Pitfalls to Avoid

• Don't assume the medication is working – At 180 mg with TSH of 10.8, either compliance is poor, absorption is impaired, or the formulation is inadequate 1
• Don't ignore T3 levels – Desiccated thyroid contains both T4 and T3 in a 4:1 ratio; some patients on DTE develop supraphysiologic T3 levels with low T4, which can be misleading 4, 5
• Beware of lot-to-lot variability – DTE remains outside formal FDA oversight for consistency, and T4/T3 content is monitored only by manufacturers 6

Alternative Considerations

If the patient fails to respond to doses above 180-210 mg:

• Consider switching to levothyroxine monotherapy – This provides more predictable dosing and avoids the T3 fluctuations seen with DTE 4, 7
• Evaluate for malabsorption – Celiac disease, atrophic gastritis, or medications interfering with absorption 7
• Assess for other endocrine disorders – Concomitant adrenal insufficiency or diabetes can affect thyroid hormone requirements 1